{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,18]],"date-time":"2026-10-18T02:20:29Z","timestamp":1792290029494,"version":"4.4.0"},"reference-count":30,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,4,21]],"date-time":"2021-04-21T00:00:00Z","timestamp":1618963200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/3.0\/igo\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2021,11]]},"DOI":"10.1016\/j.vaccine.2021.04.040","type":"journal-article","created":{"date-parts":[[2021,5,4]],"date-time":"2021-05-04T19:06:04Z","timestamp":1620155164000},"page":"C3-C11","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"S3","title":["Nigeria experience on the use of polio assets for the 2017\/18 measles vaccination campaign follow-up"],"prefix":"10.1016","volume":"39","author":[{"given":"Avuwa Joseph","family":"Oteri","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Usman","family":"Adamu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Boubacar","family":"Dieng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samuel","family":"Bawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nomhwange","family":"Terna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Nsubuga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eme T.","family":"Owoaje","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Modibo","family":"Kassogue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne Eudes","family":"Jean Baptiste","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fiona","family":"Braka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Faisal","family":"Shuaib","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2021.04.040_b0005","unstructured":"Global Polio Eradication Initiative. History of Polio \u2013 GPEI [Internet]. WHO. [cited 2020 Mar 31]. Available from: http:\/\/polioeradication.org\/polio-today\/history-of-polio\/."},{"key":"10.1016\/j.vaccine.2021.04.040_b0010","unstructured":"The Global Polio Eradication Initiative. Contributions and Pledges to the Global Polio Eradication Initiative , 1985-2019 G7 Countries & European Commission Total for Non-G7 OECD Countries Private Sector\/Non-Governmental Donors. 2016;(April):2019."},{"key":"10.1016\/j.vaccine.2021.04.040_b0015","doi-asserted-by":"crossref","DOI":"10.1038\/nrmicro906","article-title":"Polio eradication, cessation of vaccination and re-emergence of disease","author":"Minor","year":"2004","journal-title":"Nat Rev Microbiol"},{"issue":"3","key":"10.1016\/j.vaccine.2021.04.040_b0020","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1371\/journal.pmed.0040073","article-title":"What led to the Nigerian boycott of the polio vaccination campaign?","volume":"4","author":"Jegede","year":"2007","journal-title":"PLoS Med"},{"key":"10.1016\/j.vaccine.2021.04.040_b0025","doi-asserted-by":"crossref","DOI":"10.1080\/10410236.2011.566830","article-title":"Local Resistance to the Global Eradication of Polio: Newspaper Coverage of the 2003\u20132004 Vaccination Stoppage in Northern Nigeria","author":"Olufowote","year":"2011","journal-title":"Health Commun"},{"issue":"1","key":"10.1016\/j.vaccine.2021.04.040_b0030","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/S0891-5520(05)70267-1","article-title":"Poliomyelitis Eradication: Progress, Challenges for the End Game, and Preparation for the Post-Eradication Era","volume":"15","author":"Sutter","year":"2001","journal-title":"Infect Dis Clin North Am [Internet]"},{"key":"10.1016\/j.vaccine.2021.04.040_b0035","unstructured":"Matlin SA, Haslegrave M, Told M, Piper J. GLOBAL POLIO ERADICATION: ACHIEVEMENTS, CHALLENGES AND LESSONS LEARNED; 2017."},{"key":"10.1016\/j.vaccine.2021.04.040_b0040","doi-asserted-by":"crossref","unstructured":"Craig AS, Haydarov R, O\u2019malley H, Galway M, Dao H, Ngongo N, et al. The Public Health Legacy of Polio Eradication in Africa. \u2022 S343 J Infect Dis \u00ae [Internet]. 2017 [cited 2019 Mar 29];2017(1):343\u201350. Available from: https:\/\/academic.oup.com\/jid\/article-abstract\/216\/suppl_1\/S343\/3935061.","DOI":"10.1093\/infdis\/jix034"},{"issue":"2","key":"10.1016\/j.vaccine.2021.04.040_b0045","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.vaccine.2010.10.026","article-title":"Economic analysis of the global polio eradication initiative","volume":"29","author":"Duintjer Tebbens","year":"2010","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2021.04.040_b0050","unstructured":"Global Polio Eradication Initiative. Nigeria \u2013 GPEI [Internet]. 2017 [cited 2020 Mar 31]. Available from: http:\/\/polioeradication.org\/where-we-work\/nigeria\/."},{"issue":"2","key":"10.1016\/j.vaccine.2021.04.040_b0055","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1377\/hlthaff.2015.1104","article-title":"The Global Polio Eradication Initiative: Progress, Lessons Learned, And Polio Legacy Transition Planning","volume":"35","author":"Cochi","year":"2016","journal-title":"Health Aff [Internet]"},{"key":"10.1016\/j.vaccine.2021.04.040_b0060","unstructured":"Global Polio Eradication Initiative. Polio Eradication and Endgame Strategic Plan 2013\u20132018. In: Polio Eradication and Endgame Strategic Plan 2013\u20132018 [Internet]. 2013. p. 1\u20138. Available from: www.polioeradication.org."},{"key":"10.1016\/j.vaccine.2021.04.040_b0065","unstructured":"Polio Partners Group GPEI. Post-Certification Strategy (PCS) Update Polio Eradication and Endgame Strategy [Internet]. Available from: http:\/\/polioeradication.org\/polio-today\/preparing-for-a-polio-free-world\/transition-planning\/polio-post-certification-strategy\/."},{"key":"10.1016\/j.vaccine.2021.04.040_b0070","unstructured":"Transition Planning \u2013 GPEI [Internet]. Available from: http:\/\/polioeradication.org\/polio-today\/preparing-for-a-polio-free-world\/transition-planning\/."},{"key":"10.1016\/j.vaccine.2021.04.040_b0075","doi-asserted-by":"crossref","unstructured":"Rutter PD, Hinman AR, Hegg L, King D, Sosler S, Swezy V, et al. Transition Planning For After Polio Eradication. J Infect Dis Transit Plan After Polio Erad \u2022 JID [Internet]. 2017 [cited 2021 Feb 10];2017(S1):287\u201392. Available from: https:\/\/academic.oup.com\/jid\/article\/216\/suppl_1\/S287\/3935060.","DOI":"10.1093\/infdis\/jix026"},{"key":"10.1016\/j.vaccine.2021.04.040_b0080","unstructured":"The Global Polio Eradication Initiative. Asset Mapping Data Overview (As of July 2016) A. Polio Funded Personnel-Number of Human Resources Involved in Support of Polio Eradication by Partner Organization according to State Nigeria Asset Mapping Data (At-a-Glance) [Internet]. 2017 [cited 2021 Feb 10]. Available from: https:\/\/polioeradication.org\/wp-content\/uploads\/2017\/12\/polio-transition-nigeria-asset-map-november-2017.pdf."},{"key":"10.1016\/j.vaccine.2021.04.040_b0085","doi-asserted-by":"crossref","first-page":"S67","DOI":"10.1093\/infdis\/jiv493","article-title":"Tracking vaccination teams during polio campaigns in Northern Nigeria by use of geographic information system technology: 2013\u20132015","volume":"213","author":"Touray","year":"2016","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2021.04.040_b0090","doi-asserted-by":"crossref","first-page":"S116","DOI":"10.1093\/infdis\/jiv494","article-title":"Strategic engagement of technical surge capacity for intensified polio eradication initiative in Nigeria, 2012\u20132015","volume":"213","author":"Yehualashet","year":"2016","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2021.04.040_b0095","unstructured":"WHO. Nigeria: WHO and UNICEF estimates of immunization coverage: 2018 revision [Internet]. 20Available from: https:\/\/www.who.int\/immunization\/monitoring_surveillance\/data\/phl.pdf."},{"key":"10.1016\/j.vaccine.2021.04.040_b0100","unstructured":"World Health Organization. Global Vaccine Action Plan(GVAP) 2011-2020 [Internet]. 2013. Available from: https:\/\/www.who.int\/immunization\/global_vaccine_action_plan\/GVAP_doc_2011_2020\/en\/."},{"key":"10.1016\/j.vaccine.2021.04.040_b0105","doi-asserted-by":"crossref","unstructured":"Portnoy A, Jit M, Helleringer S, Verguet S. Impact of measles supplementary immunization activities on reaching children missed by routine programs. Vaccine [Internet]. 2018 [cited 2019 Mar 29];36(1):170\u20138. Available from: https:\/\/www-ncbi-nlm-nih-gov.ezproxy1.bath.ac.uk\/pmc\/articles\/PMC5949217\/.","DOI":"10.1016\/j.vaccine.2017.10.080"},{"key":"10.1016\/j.vaccine.2021.04.040_b0110","unstructured":"World Health Organization. GLOBAL MEASLES AND RUBELLA STRATEGIC PLAN 2012-20202 [Internet]. 2012 [cited 2019 Mar 29]. Available from: http:\/\/www.who.int\/about\/licensing\/copyright_form\/en\/index.html."},{"key":"10.1016\/j.vaccine.2021.04.040_b0115","doi-asserted-by":"crossref","unstructured":"Goodson JL, Alexander JP, Linkins RW, Orenstein WA. Measles and rubella elimination: learning from polio eradication and moving forward with a diagonal approach. Expert Rev Vaccines [Internet]. 2017 Dec 2 [cited 2019 Mar 29];16(12):1203\u201316. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/29037086.","DOI":"10.1080\/14760584.2017.1393337"},{"key":"10.1016\/j.vaccine.2021.04.040_b0120","doi-asserted-by":"crossref","DOI":"10.1016\/j.jvacx.2020.100056","article-title":"Geospatial variation in measles vaccine coverage through routine and campaign strategies in Nigeria: analysis of recent household surveys","author":"Edson Utazi","year":"2020","journal-title":"Vaccine X"},{"key":"10.1016\/j.vaccine.2021.04.040_b0125","unstructured":"Independent Monitoring Board of the Global Polio Eradication Initiative. Review of Polio Endemic Countries. 2018;(September)."},{"key":"10.1016\/j.vaccine.2021.04.040_b0130","doi-asserted-by":"crossref","unstructured":"Barau I, Zubairu M, Mwanza MN, Seaman VY. Improving Polio Vaccination Coverage in Nigeria Through the Use of Geographic Information System Technology. J Infect Dis [Internet]. 2014 Nov;210(suppl_1):S102\u201310. Available from: https:\/\/academic.oup.com\/jid\/article-lookup\/doi\/10.1093\/infdis\/jiu010.","DOI":"10.1093\/infdis\/jiu010"},{"key":"10.1016\/j.vaccine.2021.04.040_b0135","doi-asserted-by":"crossref","unstructured":"Gali E, Mkanda P, Banda R, Korir C, Bawa S, Warigon C, et al. Revised Household-Based Microplanning in Polio Supplemental Immunization Activities in Kano State, Nigeria. 2013\u20132014. J Infect Dis [Internet]. 2016 May 1;213(suppl 3):S73\u20138. Available from: https:\/\/academic.oup.com\/jid\/article-lookup\/doi\/10.1093\/infdis\/jiv589.","DOI":"10.1093\/infdis\/jiv589"},{"key":"10.1016\/j.vaccine.2021.04.040_b0140","doi-asserted-by":"crossref","unstructured":"Tegegne SG, MKanda P, Yehualashet YG, Erbeto TB, Touray K, Nsubuga P, et al. Implementation of a Systematic Accountability Framework in 2014 to Improve the Performance of the Nigerian Polio Program. J Infect Dis [Internet]. 2016 May 1;213(suppl 3):S96\u2013100. Available from: https:\/\/academic.oup.com\/jid\/article-lookup\/doi\/10.1093\/infdis\/jiv492.","DOI":"10.1093\/infdis\/jiv492"},{"key":"10.1016\/j.vaccine.2021.04.040_b0145","doi-asserted-by":"crossref","DOI":"10.1093\/infdis\/jiv581","article-title":"The role of the polio program infrastructure in response to Ebola virus disease outbreak in Nigeria 2014","author":"Vaz","year":"2016","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2021.04.040_b0150","doi-asserted-by":"crossref","unstructured":"Goodson JL, Alexander JP, Linkins RW, Orenstein WA. Measles and rubella elimination: learning from polio eradication and moving forward with a diagonal approach. Expert Rev Vaccines [Internet]. 2017 Dec 2 [cited 2020 Apr 2];16(12):1203\u201316. Available from: https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/14760584.2017.1393337.","DOI":"10.1080\/14760584.2017.1393337"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X21004977?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X21004977?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T11:04:45Z","timestamp":1759403085000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X21004977"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11]]},"references-count":30,"alternative-id":["S0264410X21004977"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2021.04.040","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2021,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Nigeria experience on the use of polio assets for the 2017\/18 measles vaccination campaign follow-up","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2021.04.040","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"name":"copyright","label":"Copyright"}]}}